| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,263 |
14,287 |
$3.93M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,781 |
3,496 |
$2.35M |
| 80053 |
Comprehensive metabolic panel |
27,490 |
21,718 |
$1.95M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,535 |
11,767 |
$1.57M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,293 |
14,961 |
$1.44M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,853 |
2,605 |
$1.25M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,952 |
2,806 |
$1.20M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,231 |
1,094 |
$892K |
| 93458 |
|
751 |
685 |
$699K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
5,440 |
2,070 |
$542K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,143 |
1,077 |
$524K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
842 |
803 |
$418K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,541 |
1,395 |
$414K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,590 |
2,226 |
$403K |
| C1776 |
Joint device (implantable) |
402 |
284 |
$332K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,024 |
4,452 |
$200K |
| 43235 |
|
714 |
668 |
$194K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,755 |
5,257 |
$174K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,635 |
1,560 |
$167K |
| 59025 |
Fetal non-stress test |
1,765 |
1,329 |
$159K |
| 11045 |
|
339 |
150 |
$158K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
508 |
443 |
$141K |
| 27447 |
|
18 |
16 |
$129K |
| 93975 |
|
303 |
288 |
$111K |
| 73562 |
|
840 |
757 |
$104K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,336 |
1,246 |
$92K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
223 |
196 |
$88K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
307 |
289 |
$86K |
| 80050 |
General health panel |
633 |
614 |
$83K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,373 |
6,577 |
$82K |
| C1874 |
Stent, coated/covered, with delivery system |
13 |
13 |
$76K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,543 |
1,792 |
$46K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
866 |
842 |
$46K |
| 58571 |
|
12 |
12 |
$44K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
702 |
657 |
$43K |
| G0378 |
Hospital observation service, per hour |
9,543 |
4,459 |
$40K |
| 71046 |
Radiologic examination, chest; 2 views |
5,663 |
5,282 |
$36K |
| 47563 |
|
13 |
13 |
$35K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,282 |
1,199 |
$34K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
505 |
483 |
$25K |
| 73630 |
|
387 |
364 |
$23K |
| 70486 |
|
108 |
101 |
$21K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
573 |
531 |
$20K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,328 |
6,403 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,381 |
13,159 |
$20K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,030 |
943 |
$18K |
| 73030 |
|
588 |
523 |
$17K |
| 73610 |
|
208 |
192 |
$17K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
152 |
126 |
$16K |
| 73130 |
|
216 |
203 |
$15K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
52 |
52 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,839 |
9,220 |
$14K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
755 |
676 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,522 |
1,142 |
$11K |
| 93976 |
|
255 |
244 |
$11K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
189 |
181 |
$9K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
106 |
105 |
$9K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
929 |
843 |
$9K |
| 88304 |
|
1,261 |
1,177 |
$8K |
| 72100 |
|
153 |
145 |
$8K |
| C1781 |
Mesh (implantable) |
109 |
101 |
$8K |
| 96376 |
|
2,491 |
1,968 |
$8K |
| 87186 |
|
2,241 |
2,003 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
9,445 |
8,303 |
$7K |
| 72131 |
|
29 |
24 |
$7K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
44 |
41 |
$7K |
| 73110 |
|
28 |
26 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,779 |
12,188 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,248 |
6,384 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,442 |
4,834 |
$5K |
| 93971 |
|
815 |
731 |
$5K |
| 99215 |
Prolong outpt/office vis |
56 |
44 |
$5K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
47 |
45 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
312 |
284 |
$4K |
| 73560 |
|
240 |
193 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$3K |
| A4649 |
Surgical supply; miscellaneous |
544 |
470 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
336 |
178 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
217 |
166 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,383 |
2,171 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,071 |
2,813 |
$3K |
| 86900 |
|
2,833 |
2,435 |
$3K |
| 71250 |
|
13 |
13 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,396 |
895 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
33,094 |
25,063 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,517 |
1,035 |
$2K |
| 87428 |
|
1,849 |
1,771 |
$2K |
| 87088 |
|
2,696 |
2,371 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,966 |
3,195 |
$1K |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$1K |
| 84484 |
|
9,977 |
6,380 |
$1K |
| 84703 |
|
5,334 |
4,837 |
$1K |
| 81001 |
|
10,411 |
9,285 |
$1K |
| 94761 |
|
529 |
408 |
$929.12 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,549 |
1,460 |
$789.76 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
80 |
70 |
$724.17 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,296 |
1,252 |
$711.13 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
16 |
14 |
$588.39 |
| 74018 |
|
405 |
364 |
$565.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,295 |
6,914 |
$488.21 |
| 83690 |
|
6,723 |
6,005 |
$448.99 |
| 81025 |
|
4,574 |
4,279 |
$418.92 |
| 87400 |
|
973 |
906 |
$414.30 |
| 36415 |
Collection of venous blood by venipuncture |
41,128 |
29,549 |
$401.56 |
| 83605 |
|
4,504 |
3,729 |
$399.49 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,506 |
4,995 |
$399.07 |
| 85379 |
|
1,522 |
1,387 |
$391.62 |
| 83880 |
|
2,190 |
1,884 |
$386.22 |
| 82962 |
|
8,143 |
3,932 |
$374.14 |
| 73502 |
|
53 |
49 |
$358.26 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14 |
12 |
$335.73 |
| A9270 |
Non-covered item or service |
9,799 |
1,414 |
$290.79 |
| 85610 |
|
8,549 |
7,090 |
$290.36 |
| 97597 |
|
23 |
12 |
$275.60 |
| 85027 |
|
3,918 |
3,249 |
$265.32 |
| 84702 |
|
1,381 |
1,265 |
$257.99 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
38 |
36 |
$256.30 |
| 81003 |
|
8,273 |
7,523 |
$252.67 |
| 83735 |
|
4,656 |
3,617 |
$245.49 |
| 90715 |
|
600 |
572 |
$243.20 |
| 85730 |
|
4,628 |
4,071 |
$208.23 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,996 |
7,374 |
$207.12 |
| 97162 |
|
788 |
683 |
$193.03 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,507 |
8,451 |
$123.93 |
| 87040 |
|
2,645 |
1,710 |
$122.19 |
| 80061 |
Lipid panel |
385 |
316 |
$121.46 |
| 82550 |
|
1,775 |
1,537 |
$115.14 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,609 |
7,154 |
$110.11 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,342 |
3,081 |
$107.02 |
| 88342 |
|
705 |
675 |
$94.08 |
| 87081 |
|
665 |
643 |
$91.71 |
| J3490 |
Unclassified drugs |
431 |
371 |
$89.53 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,225 |
1,019 |
$86.39 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
671 |
586 |
$85.07 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12,964 |
10,614 |
$84.65 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
4,101 |
3,749 |
$84.26 |
| 97165 |
|
690 |
624 |
$80.54 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,862 |
2,478 |
$75.41 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,961 |
8,379 |
$73.84 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,055 |
814 |
$73.77 |
| J2060 |
Injection, lorazepam, 2 mg |
2,024 |
1,550 |
$65.43 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,517 |
1,333 |
$63.10 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,199 |
1,577 |
$60.95 |
| 82947 |
|
838 |
396 |
$52.56 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,567 |
2,137 |
$50.88 |
| 73090 |
|
19 |
14 |
$50.60 |
| 76801 |
|
202 |
176 |
$46.38 |
| J2704 |
Injection, propofol, 10 mg |
10,133 |
7,520 |
$43.11 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
56 |
50 |
$42.99 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
56 |
50 |
$42.99 |
| 87070 |
|
540 |
476 |
$41.17 |
| 80047 |
|
1,563 |
1,354 |
$41.04 |
| 94760 |
|
773 |
611 |
$40.51 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,122 |
4,381 |
$34.48 |
| 87077 |
|
1,276 |
1,122 |
$28.31 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
515 |
442 |
$27.43 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,928 |
1,725 |
$26.86 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
756 |
721 |
$25.00 |
| 86901 |
|
2,834 |
2,435 |
$22.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
853 |
796 |
$22.30 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
506 |
473 |
$21.54 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
3,406 |
2,244 |
$20.10 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
622 |
303 |
$17.70 |
| 86850 |
|
2,584 |
2,216 |
$15.16 |
| 82077 |
|
349 |
329 |
$13.82 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
9,334 |
8,075 |
$13.14 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,994 |
1,269 |
$9.54 |
| 87205 |
|
642 |
560 |
$9.43 |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,694 |
2,288 |
$9.19 |
| 97116 |
|
715 |
395 |
$7.21 |
| C9113 |
Injection, pantoprazole sodium, per vial |
550 |
395 |
$7.06 |
| 80076 |
|
165 |
161 |
$6.54 |
| J7050 |
Infusion, normal saline solution, 250 cc |
491 |
379 |
$5.18 |
| 87420 |
|
125 |
122 |
$4.68 |
| 84100 |
|
287 |
227 |
$4.21 |
| 87147 |
|
277 |
246 |
$3.91 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
228 |
182 |
$0.80 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,949 |
1,715 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
239 |
216 |
$0.00 |
| A6255 |
Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
62 |
55 |
$0.00 |
| 85347 |
|
279 |
169 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
631 |
547 |
$0.00 |
| 97161 |
|
1,131 |
992 |
$0.00 |
| 99152 |
|
1,747 |
1,530 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
167 |
146 |
$0.00 |
| 84439 |
|
98 |
93 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
295 |
230 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
376 |
311 |
$0.00 |
| C1758 |
Catheter, ureteral |
1,126 |
996 |
$0.00 |
| 85007 |
|
214 |
184 |
$0.00 |
| A6258 |
Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
226 |
204 |
$0.00 |
| 80143 |
|
316 |
284 |
$0.00 |
| 80179 |
|
281 |
259 |
$0.00 |
| 29125 |
|
13 |
13 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
48 |
40 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
224 |
168 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
15 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
87 |
82 |
$0.00 |
| 96367 |
|
19 |
14 |
$0.00 |
| A6403 |
Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing |
56 |
43 |
$0.00 |
| 87075 |
|
16 |
12 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
49 |
40 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
184 |
101 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
166 |
159 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
20 |
12 |
$0.00 |
| 84600 |
|
13 |
13 |
$0.00 |
| 83540 |
|
12 |
12 |
$0.00 |
| 82948 |
|
24 |
19 |
$0.00 |
| C1769 |
Guide wire |
1,937 |
1,657 |
$0.00 |
| 72170 |
|
29 |
24 |
$0.00 |
| 86140 |
|
164 |
148 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
1,758 |
1,613 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,600 |
1,450 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
1,188 |
1,039 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
35 |
25 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
454 |
317 |
$0.00 |
| 97035 |
|
441 |
227 |
$0.00 |
| 80329 |
|
664 |
436 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
131 |
107 |
$0.00 |
| 80320 |
|
1,481 |
1,347 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
139 |
115 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
33 |
28 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
94 |
93 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
284 |
269 |
$0.00 |
| 88307 |
|
172 |
151 |
$0.00 |
| A4215 |
Needle, sterile, any size, each |
395 |
388 |
$0.00 |
| 87807 |
|
161 |
159 |
$0.00 |
| 84132 |
|
44 |
38 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
96 |
94 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
306 |
212 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
79 |
59 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
19 |
15 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
16 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
34 |
25 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
24 |
13 |
$0.00 |
| 36416 |
|
31 |
18 |
$0.00 |
| 82553 |
|
45 |
34 |
$0.00 |
| 97166 |
|
31 |
28 |
$0.00 |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
13 |
12 |
$0.00 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
26 |
25 |
$0.00 |